Hejazi, Rawan
Alghamdi, Thamer H.
Salih, Rihab
Naeim, Yousra
Althiyab, Hamad
AlAnzi, Talal
Mohamed, Sarar
Alfadhel, Majid
ALTassan, Ruqaiah Saleh
Al-Hassnan, Zuhair N.
AlSayed, Moeenaldeen https://orcid.org/0000-0003-1995-8465
Funding for this research was provided by:
Immedica Pharma AB (Immedica Pharma AB)
Article History
Received: 30 March 2025
Accepted: 14 January 2026
First Online: 30 January 2026
Declarations
:
: King Faisal Specialist Hospital and Research Centre institutional review board (IRB) approved this study (RAC # 2231012) and publication (# 2255119). Clinical trial number: not applicable.
: Written consent was obtained from all the participants.
: The authors declare no conflicts of interest.